<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">kurskvest</journal-id><journal-title-group><journal-title xml:lang="ru">Человек и его здоровье</journal-title><trans-title-group xml:lang="en"><trans-title>Humans and their health</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1998-5746</issn><issn pub-type="epub">1998-5754</issn><publisher><publisher-name>Kursk State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21626/vestnik/2023-3/07</article-id><article-id custom-type="edn" pub-id-type="custom">JVDAJU</article-id><article-id custom-type="elpub" pub-id-type="custom">kurskvest-1214</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕДИКО-БИОЛОГИЧЕСКИЕ НАУКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MEDICOBIOLOGICAL SCIENCES</subject></subj-group></article-categories><title-group><article-title>Состояние функций нервной системы крыс Вистар при применении пептида тафтцин-ПГП (селанк) в условиях иммобилизационного стресса</article-title><trans-title-group xml:lang="en"><trans-title>State of nervous system functions of Wistar rats when using peptide taftsin-PGP (selank) in restraint stress</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7745-2599</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бобынцев</surname><given-names>Игорь Иванович</given-names></name><name name-style="western" xml:lang="en"><surname>Bobyntsev</surname><given-names>Igor I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, профессор, заведующий кафедрой патофизиологии, директор НИИ общей патологии, КГМУ, г. Курск</p></bio><bio xml:lang="en"><p>Dr. Sci. (Med.), Professor, Head of the Department of Pathophysiology, Head of the Research Institute of General Pathology, KSMU, Kursk, Russian Federation</p></bio><email xlink:type="simple">bobig@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-2426-358X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кривошлыкова</surname><given-names>Марина Сергеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Krivoshlykova</surname><given-names>Marina S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры фармакологии, КГМУ, г. Курск</p></bio><bio xml:lang="en"><p>Assistant lecturer at the Department of Pharmacology, KSMU, Kursk, Russian Federation</p></bio><email xlink:type="simple">lew_marina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2889-155X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Медведева</surname><given-names>Ольга Анатольевна</given-names></name><name name-style="western" xml:lang="en"><surname>Medvedeva</surname><given-names>Olga A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р биол. наук, профессор, заведующий кафедрой микробиологии, вирусологии, иммунологии, КГМУ, г. Курск</p></bio><bio xml:lang="en"><p>Dr. Sci. (Biol.), Professor, Head of Department of Microbiology, Virology, Immunology, KSMU, Kursk, Russian Federation</p></bio><email xlink:type="simple">olgafrida@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1529-6014</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ворвуль</surname><given-names>Антон Олегович</given-names></name><name name-style="western" xml:lang="en"><surname>Vorvul</surname><given-names>Anton O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры патофизиологии, мл. науч. сотрудник НИИ общей патологии, КГМУ, г. Курск</p></bio><bio xml:lang="en"><p>Assistant lecturer at the Department of Pathophysiology, Junior Researcher at the Research Institute of General Pathology, KSMU, Kursk, Russian Federation</p></bio><email xlink:type="simple">vorvul1996@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3927-8590</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андреева</surname><given-names>Людмила Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Andreeva</surname><given-names>Liudmila A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>зам. зав. лабораторией молекулярной фармакологии пептидов, НИЦ «Курчатовский институт», г. Москва</p></bio><bio xml:lang="en"><p>Deputy Head of the Laboratory of Molecular pharmacology of peptides, NRC « Kurchatov Institute», Moscow, Russian Federation</p></bio><email xlink:type="simple">landr@img.ras.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1294-102X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мясоедов</surname><given-names>Николай Федорович</given-names></name><name name-style="western" xml:lang="en"><surname>Myasoedov</surname><given-names>Nikolai F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р хим. наук, профессор, зав. лабораторией молекулярной фармакологии пептидов, НИЦ «Курчатовский институт», г. Москва</p></bio><bio xml:lang="en"><p>Dr. Sci. (Chem.), Professor, Head of the Laboratory of Molecular pharmacology of peptides, NRC « Kurchatov Institute», Moscow, Russian Federation</p></bio><email xlink:type="simple">nfm@img.ras.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Курский государственный медицинский университет (КГМУ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kursk State Medical University (KSMU)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Национальный исследовательский центр «Курчатовский институт» (НИЦ «Курчатовский институт»)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Research Centr «Kurchatov Institute» (NRC «Kurchatov Institute»)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>30</day><month>11</month><year>2023</year></pub-date><volume>26</volume><issue>3</issue><fpage>58</fpage><lpage>68</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бобынцев И.И., Кривошлыкова М.С., Медведева О.А., Ворвуль А.О., Андреева Л.А., Мясоедов Н.Ф., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Бобынцев И.И., Кривошлыкова М.С., Медведева О.А., Ворвуль А.О., Андреева Л.А., Мясоедов Н.Ф.</copyright-holder><copyright-holder xml:lang="en">Bobyntsev I.I., Krivoshlykova M.S., Medvedeva O.A., Vorvul A.O., Andreeva L.A., Myasoedov N.F.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.kursk-vestnik.ru/jour/article/view/1214">https://www.kursk-vestnik.ru/jour/article/view/1214</self-uri><abstract><p>Цель исследования - изучение состояния функций нервной системы крыс Вистар при применении пептида тафтцин-ПГП в условиях иммобилизационного стресса. Материалы и методы. Эксперименты выполнены на 45 крысах-самцах Вистар массой 200-230 г. Пептид селанк (Thr-Lys-Pro-Arg-Pro-Gly-Pro) вводили внутрибрюшинно в дозах 80, 250 и 750 мкг/кг за 15 минут до стрессорного воздействия. Животные были разделены на 5 групп (n = 9): 1 - контроль (нестрессированные животные, которым вводили изотопический раствор NaCl); 2 - стресс (стрессированные животные, которым вводили изотопический раствор натрия хлорида); 3-5 - стресс+тафтцин-ПГП в дозах 80, 250 и 750 мкг/кг. Животные подвергались стрессу в течение 28 дней, с 15-й по 28-й дни животным вводили селанк/изотонический раствор NaCl. Нейротропные эффекты селанка оценивали в тестах приподнятого крестообразного лабиринта (ПКЛ), открытого поля (ОП) и принудительного плавания по Порсолту. Для оценки выраженности стресс-реакции оценивали концентрацию кортикостерона в сыворотке крови крыс с помощью иммуноферментного анализа. Результаты. Установлено, что 28-дневный иммобилизационный стресс вызывал нарушения функций нервной системы в виде повышения уровня тревожности, горизонтальной, вертикальной, локомотивной активности, эмоциональности и выраженности депрессивного поведения, а также повышение концентрации кортикостерона в сыворотке крови экспериментальных животных. Введение тафтцина-ПГП на фоне предварительного стрессирования (с 15-й по 28-й дни эксперимента) способствовало снижению выраженности стресс индуцированных изменений поведения крыс: в дозе 750 мкг/кг пептид оказывал анксиолитическое действие, 250 мкг/кг - антидепрессивное. При этом данные изменения происходили на фоне значимого снижения уровня кортикостерона в сыворотке крови. Заключение. Таким образом, селанк корригирует стресс индуцированные изменения состояния функций нервной системы в условиях 28-дневного иммобилизационного стресса.</p></abstract><trans-abstract xml:lang="en"><p>The aim of the study was to investigate the state of functions of the nervous system of Wistar rats upon application of the peptide taftsin-PGP under conditions of chronic stress. Materials and methods. The experiments were performed on 45 male Wistar rats weighing 200-230 g. Selank peptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) was injected intraperitoneally at doses of 80, 250 and 750 μg/kg 15 min before stressor exposure. Animals were divided into 5 groups (n = 9): 1 - control (non-stressed animals injected with saline); 2 - stress (stressed animals injected with saline); 3-5 - stress+taftsin-PGP at doses of 80, 250 and 750 µg/kg. Animals were stressed for 28 days; from days 15 to 28, they were injected with selank/saline. The neurotropic effects of selank were evaluated in the elevated plus-maze, open field (OF) and forced swimming tests. To assess the severity of stress response, the concentration of corticosterone in rat serum was evaluated using enzyme immunoassay. Results. It was found that 28-day immobilisation stress caused disturbances of nervous system functions in the form of increased anxiety, horizontal, vertical, locomotor activity, emotionality and expression of depressive behaviour, as well as increased concentration of corticosterone in blood serum of experimental animals. Taftsin-PGP administration against the background of preliminary stressing (from the 15th to the 28th day of the experiment) contributed to a decrease in the severity of stress-induced behavioural changes in rats: at a dose of 750 µg/kg the peptide had anxiolytic effect, 250 µg/kg - antidepressant effect. At the same time, these changes occurred against the background of a significant decrease in serum corticosterone level. Conclusion. Thus, selank corrects stress-induced changes in the state of nervous system functions under 28-day restraint stress.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>тафтцин-ПГП (селанк)</kwd><kwd>иммобилизационный стресс</kwd><kwd>тревожность</kwd><kwd>депрессия</kwd><kwd>эмоциональность</kwd><kwd>локомоторная активность</kwd><kwd>кортикостерон</kwd></kwd-group><kwd-group xml:lang="en"><kwd>taftsin-PGP (selank)</kwd><kwd>restraint stress</kwd><kwd>anxiety</kwd><kwd>depression</kwd><kwd>emotionality</kwd><kwd>locomotor activity</kwd><kwd>corticosterone</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Koroleva S.V., Mjasoedov N.F. Physiological effects of Selank and its fragments. Biol Bull. 2019;46(4): 407-414. DOI: 10.1134/S1062359019040071.</mixed-citation><mixed-citation xml:lang="en">Koroleva S.V., Mjasoedov N.F. Physiological effects of Selank and its fragments. Biol Bull. 2019;46(4): 407-414. DOI: 10.1134/S1062359019040071.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Vorvul A.O., Bobyntsev I.I., Svishcheva M.V., Medvedeva O.A., Mukhina A.Y., Andreeva L.A. The Peptide ACTH4-7-PGP Corrects Behavior and Corticosterone Levels in Rats in Chronic Stress. Neurosci Behav Physiol. 2022;52(4):574-581. DOI: 10.1007/s11055-022-01277-5.</mixed-citation><mixed-citation xml:lang="en">Vorvul A.O., Bobyntsev I.I., Svishcheva M.V., Medvedeva O.A., Mukhina A.Y., Andreeva L.A. The Peptide ACTH4-7-PGP Corrects Behavior and Corticosterone Levels in Rats in Chronic Stress. Neurosci Behav Physiol. 2022;52(4):574-581. DOI: 10.1007/s11055-022-01277-5.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Vorvul A.O., Bobyntsev I.I., Medvedeva O.A., Mukhina A.Y., Svishcheva M.V., Azarova I.E., Andreeva L.A., Myasoedov N.F. ACTH(6-9)-Pro-Gly-Pro ameliorates anxiety-like and depressive-like behaviour and gut mucosal microbiota composition in rats under conditions of chronic restraint stress. Neuropeptides. 2022;93:102247. DOI: 10.1016/j.npep.2022.102247.</mixed-citation><mixed-citation xml:lang="en">Vorvul A.O., Bobyntsev I.I., Medvedeva O.A., Mukhina A.Y., Svishcheva M.V., Azarova I.E., Andreeva L.A., Myasoedov N.F. ACTH(6-9)-Pro-Gly-Pro ameliorates anxiety-like and depressive-like behaviour and gut mucosal microbiota composition in rats under conditions of chronic restraint stress. Neuropeptides. 2022;93:102247. DOI: 10.1016/j.npep.2022.102247.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Volodina M.A., Sebentsova E.A., Glazova N.Y., Manchenko D.M., Inozemtseva L.S., Dolotov O.V., Andreeva L.A., Levitskaya N.G., et al. Correction of long-lasting negative effects of neonatal isolation in white rats using semax. Acta Naturae. 2012;4(1):86-92.</mixed-citation><mixed-citation xml:lang="en">Volodina M.A., Sebentsova E.A., Glazova N.Y., Manchenko D.M., Inozemtseva L.S., Dolotov O.V., Andreeva L.A., Levitskaya N.G., et al. Correction of long-lasting negative effects of neonatal isolation in white rats using semax. Acta Naturae. 2012;4(1):86-92.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Chiba S., Numakawa T., Ninomiya M., Richards M.C., Wakabayashi C., Kunugi H. Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39(1):112-119. DOI: 10.1016/j.pnpbp.2012.05.018.</mixed-citation><mixed-citation xml:lang="en">Chiba S., Numakawa T., Ninomiya M., Richards M.C., Wakabayashi C., Kunugi H. Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39(1):112-119. DOI: 10.1016/j.pnpbp.2012.05.018.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Мухина А.Ю., Медведева О.А., Свищева М.В., Шевченко А.В., Ефремова Н.Н., Бобынцев И.И., Калуцкий П.В. Оценка состояния микробиоценоза толстой кишки экспериментальных животных в условиях иммобилизационного стресса. Астраханский медицинский журнал. 2019;14(1):54-60. DOI: 10.17021/2019.14.1.54.60. EDN: WVCDQS.</mixed-citation><mixed-citation xml:lang="en">Mukhina A.Yu., Medvedeva O.A., Svishcheva M.V., Shevchenko A.V., Efremova N.N., Bobyntsev I.I., Kalutskiy P.V. State of experimental animals’ colon microbiocenosis under restraint stress. Astrakhan medical journal. 2019;14(1):54-60 (in Russ.). DOI: 10.17021/2019.14.1.54.60. EDN: WVCDQS.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mukhina A.Y., Medvedeva O.A., Svishcheva M.V., Shevchenko A.V., Efremova N.N., Bobyntsev I.I., Kalutskii P.V., Andreeva L.A., et al. State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment. Bull Exp Biol Med. 2019;167(2):226-228. DOI: 10.1007/s10517-019-04496-y.</mixed-citation><mixed-citation xml:lang="en">Mukhina A.Y., Medvedeva O.A., Svishcheva M.V., Shevchenko A.V., Efremova N.N., Bobyntsev I.I., Kalutskii P.V., Andreeva L.A., et al. State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment. Bull Exp Biol Med. 2019;167(2):226-228. DOI: 10.1007/s10517-019-04496-y.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Svishcheva M.V., Mukhina A.Y., Medvedeva O.A., Shevchenko A.V., Bobyntsev I.I., Kalutskii P.V., Andreeva L.A., Myasoedov N.F.Composition of Colon Microbiota in Rats Treated with ACTH(4-7)-PGP Peptide (Semax) under Conditions of Restraint Stress. Bull Exp Biol Med. 2020;169(3):357-360. DOI: 10.1007/s10517-020-04886-7.</mixed-citation><mixed-citation xml:lang="en">Svishcheva M.V., Mukhina A.Y., Medvedeva O.A., Shevchenko A.V., Bobyntsev I.I., Kalutskii P.V., Andreeva L.A., Myasoedov N.F.Composition of Colon Microbiota in Rats Treated with ACTH(4-7)-PGP Peptide (Semax) under Conditions of Restraint Stress. Bull Exp Biol Med. 2020;169(3):357-360. DOI: 10.1007/s10517-020-04886-7.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Мухина А.Ю., Медведева О.А., Свищева М.В., Шевченко А.В., Ефремова Н.Н., Бобынцев И.И., Калуцкий П.В., Андреева Л.А. и др. Оценка состояния микробиоценоза толстой кишки крыс в условиях хронического иммобилизационного стресса и применения Селанка. Инфекция и иммунитет. 2019;9(5-6):805-810. DOI: 10.15789/2220-7619-2019-5-6-805-810. EDN: QFJPGY.</mixed-citation><mixed-citation xml:lang="en">Mukhina A.Yu., Medvedeva O.A., Svishcheva M.V., Shevchenko A.V., Efremova N.N., Bobyntsev I.I., Kalutsky P.V., Andreeva L.A., et al. State of rat colon microbiocenosis in chronic restraint stress treated with Selank.Russian journal of infection and immunity. 2019;9(5-6):805-810 (in Russ.). DOI: 10.15789/2220-7619-2019-5-6-805-810. EDN: QFJPGY.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mukhina A.Y., Mishina E.S., Bobyntsev I.I., Medvedeva O.A., Svishcheva M.V., Kalutskii P.V., Andreeva L.A., Myasoedov N.F. Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank. Bull Exp Biol Med. 2020;169(2):281-285. DOI: 10.1007/s10517-020-04868-9.</mixed-citation><mixed-citation xml:lang="en">Mukhina A.Y., Mishina E.S., Bobyntsev I.I., Medvedeva O.A., Svishcheva M.V., Kalutskii P.V., Andreeva L.A., Myasoedov N.F. Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank. Bull Exp Biol Med. 2020;169(2):281-285. DOI: 10.1007/s10517-020-04868-9.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Svishcheva M.V., Mishina Y.S., Medvedeva O.A., Bobyntsev I.I., Mukhina A.Y., Kalutskii P.V., Andreeva L.A., Myasoedov N.F. Morphofunctional State of the Large Intestine in Rats under Conditions of Restraint Stress and Administration of Peptide ACTH(4-7)-PGP (Semax). Bull Exp Biol Med. 2021;170(3):384-388. DOI: 10.1007/s10517-021-05072-z.</mixed-citation><mixed-citation xml:lang="en">Svishcheva M.V., Mishina Y.S., Medvedeva O.A., Bobyntsev I.I., Mukhina A.Y., Kalutskii P.V., Andreeva L.A., Myasoedov N.F. Morphofunctional State of the Large Intestine in Rats under Conditions of Restraint Stress and Administration of Peptide ACTH(4-7)-PGP (Semax). Bull Exp Biol Med. 2021;170(3):384-388. DOI: 10.1007/s10517-021-05072-z.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ворвуль А.О., Бобынцев И.И., Мишина Е.С., Медведева О.А., Андреева Л.А., Мясоедов Н.Ф. Влияние пептида АКТГ6-9-Pro-Gly-Pro на морфофункциональное состояние толстой кишки крыс в условиях хронического иммобилизационного стресса. Бюллетень Сибирской Медицины. 2023;22(2):14-20. DOI: 10.20538/1682-0363-2023-2-14-20. EDN: XQDMAJ.</mixed-citation><mixed-citation xml:lang="en">Vorvul A.O., Bobyntsev I.I., Mishina E.S., Medvedeva O.A., Andreeva L.A., Myasoedov N.F. Effects of the ACTH6-9-Pro-Gly-Pro peptide on the morphofunctional state of rat colon under conditions of chronic restraint stress. Bulletin of Siberian Medicine. 2023;22(2):14-20 (in Russ.). DOI: 10.20538/1682-0363-2023-2-14-20. EDN: XQDMAJ.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Walf A.A., Frye C.A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007;2(2):322-328. DOI: 10.1038/nprot.2007.44.</mixed-citation><mixed-citation xml:lang="en">Walf A.A., Frye C.A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007;2(2):322-328. DOI: 10.1038/nprot.2007.44.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kraeuter A.-K., Guest P.C., Sarnyai Z. The elevated plus maze test for measuring anxiety-like behavior in rodents. In: Guest P.C., editor. Pre-Clinical Models: Techniques and Protocols. New York, NY: Springer New York; 2019:69-74.</mixed-citation><mixed-citation xml:lang="en">Kraeuter A.-K., Guest P.C., Sarnyai Z. The elevated plus maze test for measuring anxiety-like behavior in rodents. In: Guest P.C., editor. Pre-Clinical Models: Techniques and Protocols. New York, NY: Springer New York; 2019:69-74.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Миронов А.Н., под ред. Руководство по проведению доклинических исследований лекарственных средств. Том I. Москва: Гриф и К; 2012. 944 с. EDN: SDEWMP.</mixed-citation><mixed-citation xml:lang="en">Mironov A.N., editor. Guidelines for conducting preclinical studies of medicines. Volume I. Moscow: Grif I K, 2012. 944 p. (in Russ.). EDN: SDEWMP.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gould T.D., Dao D.T., Kovacsics C.E. The Open Field Test. Neuromethods. 2009;42:1-20. DOI: 10.1007/978-1-60761-303-9_1.</mixed-citation><mixed-citation xml:lang="en">Gould T.D., Dao D.T., Kovacsics C.E. The Open Field Test. Neuromethods. 2009;42:1-20. DOI: 10.1007/978-1-60761-303-9_1.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kraeuter A.-K., Guest P.C., Sarnyai Z. The Forced Swim Test for Depression-Like Behavior in Rodents. In: Guest P.C., editor. Pre-Clinical Models: Techniques and Protocols. New York, NY: Springer New York; 2019:75-80. DOI: 10.1007/978-1-4939-8994-2_5.</mixed-citation><mixed-citation xml:lang="en">Kraeuter A.-K., Guest P.C., Sarnyai Z. The Forced Swim Test for Depression-Like Behavior in Rodents. In: Guest P.C., editor. Pre-Clinical Models: Techniques and Protocols. New York, NY: Springer New York; 2019:75-80. DOI: 10.1007/978-1-4939-8994-2_5.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Armario A. The forced swim test: Historical, conceptual and methodological considerations and its relationship with individual behavioral traits. Neurosci Biobehav Rev. 2021;128:74-86. DOI: 10.1016/j.neubiorev.2021.06.014.</mixed-citation><mixed-citation xml:lang="en">Armario A. The forced swim test: Historical, conceptual and methodological considerations and its relationship with individual behavioral traits. Neurosci Biobehav Rev. 2021;128:74-86. DOI: 10.1016/j.neubiorev.2021.06.014.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Зозуля А.А., Незнамов Г.Г., Сюняков Т.С., Каст П.В., Габаева М.В., Соколов О.Ю., Серебрякова Е.В., Сиранчиева О.А., Андрющенко А.В., и др. Эффективность и возможные механизмы действия нового пептидного анксиолитика Селанка при терапии генерализованного тревожного расстройства и неврастении. Журнал неврологии и психиатрии им C.C. Корсакова. 2008;108(4):38-48</mixed-citation><mixed-citation xml:lang="en">Zozulya A.A., Neznamov G.G., Syunyakov T.S., Kast P.V., Gabaeva M.V., Sokolov O.Yu., Serebryakova E.V., Siranchieva O.A., et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia. S.S. Korsakov Journal of neurology and psychiatry. 2008;108(4):38-48 (in Russ.). EDN: ISJLQR.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">V’yunova T.V., Andreeva L.A., Shevchenko K.V., Shevchenko V.P., Myasoedov N.F. Peptide regulation of specific ligand-receptor interactions of GABA with the plasma membranes of nerve cells. Neurochem J. 2014;8:259-264. DOI: 10.1134/S1819712414040114.</mixed-citation><mixed-citation xml:lang="en">V’yunova T.V., Andreeva L.A., Shevchenko K.V., Shevchenko V.P., Myasoedov N.F. Peptide regulation of specific ligand-receptor interactions of GABA with the plasma membranes of nerve cells. Neurochem J. 2014;8:259-264. DOI: 10.1134/S1819712414040114.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kolomin T.A., Agapova T.Y., Shadrina M.I., Slominskii P.A., Limborskaya S.A., Agniullin Y.V., Shram S.I., Myasoedov N.F. Changes in the transcription profile of the hippocampus in response to administration of the tuftsin analog Selank. Neuroscience and Behavioral Physiology. 2014;44(8):849-855. DOI: 10.1007/s11055-014-9992-4.</mixed-citation><mixed-citation xml:lang="en">Kolomin T.A., Agapova T.Y., Shadrina M.I., Slominskii P.A., Limborskaya S.A., Agniullin Y.V., Shram S.I., Myasoedov N.F. Changes in the transcription profile of the hippocampus in response to administration of the tuftsin analog Selank. Neuroscience and Behavioral Physiology. 2014;44(8):849-855. DOI: 10.1007/s11055-014-9992-4.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kanner B.I. Glutamate transporters from brain. A novel neurotransmitter transporter family. FEBS Lett. 1993;325(1-2):95-99. DOI: 10.1016/0014-5793(93)81421-u.</mixed-citation><mixed-citation xml:lang="en">Kanner B.I. Glutamate transporters from brain. A novel neurotransmitter transporter family. FEBS Lett. 1993;325(1-2):95-99. DOI: 10.1016/0014-5793(93)81421-u.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kolik L.G., Nadorova A.V., Antipova T.A., Kruglov S.V., Kudrin V.S., Durnev A.D. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bull Exp Biol Med. 2019;167(5):641-644. DOI: 10.1007/s10517-019-04588-9.</mixed-citation><mixed-citation xml:lang="en">Kolik L.G., Nadorova A.V., Antipova T.A., Kruglov S.V., Kudrin V.S., Durnev A.D. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bull Exp Biol Med. 2019;167(5):641-644. DOI: 10.1007/s10517-019-04588-9.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Inozemtseva L.S., Karpenko E.A., Dolotov O.V., Levitskaya N.G., Kamensky A.A., Andreeva L.A., Grivennikov I.A.Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Dokl Biol Sci. 2008;421:241-243. DOI: 10.1134/s0012496608040066.</mixed-citation><mixed-citation xml:lang="en">Inozemtseva L.S., Karpenko E.A., Dolotov O.V., Levitskaya N.G., Kamensky A.A., Andreeva L.A., Grivennikov I.A.Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Dokl Biol Sci. 2008;421:241-243. DOI: 10.1134/s0012496608040066.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Зозуля А.А., Кост Н.В., Соколов О.Ю., Габаева М.В., Гривенников И.А., Андреева Л.А., Золотарев Ю.А., Иванов С.В. и др. Ингибирующий эффект Селанка на активность энкефалиндеградирующих ферментов как один из возможных механизмов его анксиолитического действия. Бюллетень экспериментальной биологии и медицины. 2001;131(4):376-378</mixed-citation><mixed-citation xml:lang="en">Zozulya A.A., Kost N.V., Sokolov O.Yu., Gabayeva M.V., Grivennikov I.A., Andreyeva L.A., Zolotarev Yu.A., Ivanov S.V., et al. The inhibitory effect of Selank on the activity of enkephalindegradating enzymes as one of the possible mechanisms of its anxiolytic action. Bulletin of experimental biology and medicine. 2001;131(4):376-378 (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Gabellini N. Transcriptional regulation by cAMP and Ca2+ links the Na+/Ca2+ exchanger 3 to memory and sensory pathways. Mol Neurobiol. 2004;30(1):91-116. DOI: 10.1385/MN:30:1:091.</mixed-citation><mixed-citation xml:lang="en">Gabellini N. Transcriptional regulation by cAMP and Ca2+ links the Na+/Ca2+ exchanger 3 to memory and sensory pathways. Mol Neurobiol. 2004;30(1):91-116. DOI: 10.1385/MN:30:1:091.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
